FDA clears Biogen Idec's hemophilia A drug

June 6, 2014 10:29 PM

18 0

NEW YORK (AP) — U.S. regulators on Friday approved Biogen Idec's drug Eloctate, a hemophilia A treatment that is designed to last longer than older drugs.

The Food and Drug Administration approved Eloctate for use in adults and children.

Also read: FDA clears 1st generic film strip of addiction drug Suboxone

Read more

To category page